Paxton vs. Kenvue: Tylenol Dividend, Pregnancy Claims

On November fourteenth, a Texas judge will hear a request from Attorney General Ken Paxton to halt Kenvues three hundred ninety-eight million dollar dividend and prevent Tylenol marketing as safe for pregnant women. Paxtons lawsuit alleges Kenvue hid Tylenol risks to children, contradicting Kenvues safety claims. Kenvue and Johnson and Johnson argue the court lacks jurisdiction and the dividend wont cause harm. Despite unproven claims linking Tylenol to autism, doctors generally recommend Tylenol for pregnant women, while the FDA advises on growing evidence and considers new labels.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.